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ASD  Atrial septal defect 
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hpf  hour post fertilisation 
IAS  Interatrial septum 
IVS  Interventricular septum 
LA  Left atrium 
LV  Left ventricle 
RA  Right atrium 
RV  Right ventricle 
RvDIS  Right ventricular diseases 
RVH  Right ventricular hypertrophy 
TOF  Tetralogy of Fallot 
VSD  Ventricular septal defect 
 
